Prevalence and Characteristics of Clients with Co‐Occurring Disorders in Outpatient Substance Abuse Treatment

References

• Wu L T, Ringwalt C L, Williams C E. Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatr Serv 2003; 54(3)363–369, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kessler R C, Nelson C B, McGonagle K A, Liu J, Swartz M, Blazer D G. Comorbidity of DSM‐III‐R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996 Jun, 30: 17–30, [CSA]
   PubMedGoogle Scholar
• Johnson M E, Brems C, Burke S. Recognizing comorbidity among drug users in treatment. Am J Drug Alcohol Abuse 2002; 28(2)243–261, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Skinstad A H, Swain A. Comorbidity in a clinical sample of substance abusers. Am J Drug Alcohol Abuse 2001; 27(1)45–64, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hien D, Zimberg S, Weisman S, First M, Ackerman S. Dual diagnosis in urban substance abuse and mental health clinics. Psychiatr Serv 1997; 48(8)1058–1063, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kessler R C, Crum R M, Warner L A, Nelson C B, Schulenberg J, Anthony J C. Lifetime co‐occurrence of DSM‐III‐R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313–321, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kirschner J E, Curran G M, Thrush C R, Owen R R, Fortney J C, Booth B M. Depressive disorders and alcohol dependence in a community population. Commun Ment Health J 2002; 38(5)361–373, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Aharonovich E, Liu X, Nunes E, Hasin D S. Suicide attempts in substance abusers: effects of major depression in relation to substance use disorders. Am J Psychiatry 2002; 159(9)1600–1602, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hoff R A, Rosenheck R A. The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatr Serv 1999; 50(10)1309–1315, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Dickey B, Azeni H. Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care. Am J Public Health 1996; 86(7)973–977, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Brown R A, Monti P M, Myers M G, Martin R A, Rivinus T, Dubreuil M E, Rohsenow D J. Depression among cocaine abusers in treatment: relation to cocaine and alcohol use and treatment outcome. Am J Psychiatry 1998; 144: 220–225
   Google Scholar
• Carroll K M, Power M E, Bryant K, Rounsaville B J. One‐year follow‐up status of treatment‐seeking cocaine abusers: psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis 1993; 191: 71–79
   Google Scholar
• Rounsaville B J, Dolinsky Z S, Babor T F, Meyer R E. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 1987; 44: 505–513, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McLellan A T, Luborsky L, Woody G E, O'Brien C P, Druley K A. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry 1983; 40: 620–625, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services‐Substance Abuse and Mental Health Services. Co‐occuring substance abuse and mental disorders. Report to U.S. Congress. Department of Health and Human Services. 2002
   Google Scholar
• Ross H E, Glaser F B, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 1988; 45: 1023–1031, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Watkins K, Burnam A, Kung F‐Y, Paddock S. A national survey of care for persons with co‐occurring mental and substance use disorders. Psychiatr Serv 2001; 52(8)1062–1068, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Office of Applied Studies‐SAMHSA‐National Survey of Substance Abuse Treatment (N‐SSATS). Table 3.2b: substance abuse treatment facilities by type of care offered and dispensing of methadone/laam, according to facility ownership and primary focus of facility. Department of Health and Human Services. 2000
   Google Scholar
• Primm A B, Gomez M B, Tzolova‐Iontchev I, Perry W, Vu H T, Crump R M. Mental health versus substance abuse treatment programs for dually diagnosed patients. J Substance Abuse Treat 2000; 19: 285–290, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services‐Substance Abuse and Mental Health Services. SAMHSA Drug and Alcohol Services Information System Series: S‐7, Treatment Episode Data Set (TEDS), 1992–1997. Department of Health and Human Services. 1999
   Google Scholar
• Rost K, Burnam M, Smith G. Development of screeners for depressive disorder and substance disorder history. Med Care 1993; 31(3)189–200, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sturm R, Gresenz C, Sherbourne C, Minnium K, Klap R, Bhattacharya J, Farley D, Young A S, Burnam M A, Wells K B. The design of healthcare for communities: a study of health care delivery for alcohol, drug abuse, and mental health conditions. Inquiry 1999; 36: 221–233, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stein M D, Roy‐Byrne P O, McQuaid J R, Laffaye D, Russo J, McCahill M E, Katon W, Craske M, Bystritsky A, Sherbourne C D. Development of a brief diagnostic screen for panic disorder in primary care. Psychosom Med 1999; 61(3)359–364, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Dennis M L. Global Appraisal of Individual Needs (GAIN). Chestnut Health Systems, Bloomington, IL 1999
   Google Scholar
• Spitzer R L, Kroenke K, Linzer M, Hahn S R, Williams J B, deGruy F V, Brody D, Davies M. Health‐related quality of life in primary care patients with mental disorders. Results from the PRIME‐MD 1000 study. JAMA 1995; 274(19)1511–1517, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Spitzer R L, Kroenke K, Williams J BW, the Patient Health Questionnaire Primary Care Study Group. Validation and utility of a self‐report version of PRIME‐MD. JAMA 1999; 282(18)1737–1744, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Foa E B. PDS (Posttraumatic Stress Diagnostic Scale) Manual. National Computer Systems, Inc., Minneapolis, MN 1995
   Google Scholar
• Dohrenwend B P, Shrout P E, Egri G, Mendelsohn P S. Nonspecific psychological distress and other dimensions of psychopathology. Measures for use in the general population. Arch Gen Psychiatry 1980; 37(11)1229–1236, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Derogatis L R, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13(3)595–605, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Koegel P, Burnam M A. Course of Homelessness Among the Seriously Mentally Ill. National Institute on Alcohol Abuse and Alcoholism, Rockville, MD 1991
   Google Scholar
• Burnam M A, Morton S C, McGlynn E A, Peterson L P, Stecher B M, Hayes C, Vaccaro J V. An Experimental Evaluation of Residential and Nonresidential Treatment for Dually Diagnosed Homeless Adults (RAND/RP‐507). RAND, Santa Monica, CA 1996
   Google Scholar
• Lehman A F. A quality of life interview for the chronically mentally ill. Eval Prog Plan 1988; 11(1)51–62, [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Ware J E, Kosinski M, Keller S D. SF‐12: How to Score the SF‐12 Physical and Mental Health Summary Scales. The Health Institute, New England Medical Center, Boston, MA 1995
   Google Scholar
• Brick J M, Kalton G. Handling missing data in survey research. Stat Methods Surv Res 1996; 5: 215–238, [CSA]
   PubMedGoogle Scholar
• Narrow W E, Rae D S, Robins L N, Regier D A. Revised prevalence estimates of mental disorders in the United States. Arch Gen Psychiatry 2002; 59: 115–123, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Charney D A, Paraherakis A M, Negrete J C, Gill K J. The impact of depression on the outcome of addictions treatment. J Subst Abuse Treat 1998; 15(2)123–130, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Westreich L, Guedj P. Differences between men and women in dual‐diagnosis treatment. Am J Addict 1997; 6(4)311–317, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kessler R C. The National Comorbidity Survey of the United States. Int Rev Psychiatry 1994; 6: 365–376
   Google Scholar
• Wells K B, Sherbourne C D. Functioning and utility for current health of patients with depression or chronic medical conditions in managed primary care practices. Arch Gen Psychiatry 1999; 56: 897–904, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Narrow W E, Regier D A, Rae D S, Manderscheid R W, Locke B Z. Use of services by persons with mental and addictive disorders: findings from the National Institute of Mental Health Epidemiologic Catchment Area Program. Arch Gen Psychiatry 1993; 50: 95–107, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Depression Guidelines Panel. Depression in Primary Care I: Detection and Diagnosis. Department of Health and Human Services, U.S. Public Health Service, Agency for Health Care Policy and Research, Rockville, MD 1993
   Google Scholar
• Depression Guidelines Panel. Depression in Primary Care II: Treatment of Major Depression. U.S. Department of Health and Human Services, U.S. Public Health Service, Agency for Health Care Policy and Research, Rockville, MD 1993
   Google Scholar
• Van Balkom A JLM, Bakker A, Spinhoven P, Blaauw B MJW, Smeenk S, Ruesink B. A meta‐analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive‐behavioral, and combination treatments. J Nerv Ment Dis 1997; 185: 510–516, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Gould R A, Otto M W, Pollack M H, Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: a preliminary meta‐analysis. Behav Ther 1997; 28: 285–305
   Web of Science ®Google Scholar
• American Psychiatric Association (APA). Practice guidelines for the treatment of patients with panic disorder. Developed under the auspices of the Steering Committee on Practice Guidelines. Am J Psychiatry 1998; 155(suppl 5)34
   Google Scholar
• Mueser K T, Noordsy D L, Drake R E, Fox L. Integrated Treatment for Dual Disorders. The Guilford Press, New York 2003
   Google Scholar
• Nunes E V, Quitkin F M. Treatment of depression in drug‐dependent patients: effects on mood and drug use. Treatment of Drug‐Dependent Individuals with Cormorbid Mental Disorders, L S Onken, J D Baline, S Genser, A M Horton. NIDA Research Monograph, U.S. Department of Health and Human Services, Rockville, MD 1997; Vol. 172: 61–85
   Google Scholar
• Mason B J, Kocsis J H, Ritvo E C, Cutlen R B. A double‐blind, placebo‐controlled trial of Desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 1996; 275: 761–767, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nunes E V, Quitkin F M, Donovan S J, Deliyannides D, Ocepek‐Welikson K, Koenig T, Brady R, McGrath P J, Woody G. Imipramine treatment of opiate‐dependent patients with depressive disorders. Arch Gen Psychiatry 1999; 55: 153–160, [CROSSREF], [CSA]
   Google Scholar
• Cornelius J R, Salloum I M, Hasket R F, Ehler J G, Jarrett P H, Thase M E, Parel J M. Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addict Behav 1999; 24: 111–114, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Barlow D H. Anxiety disorders, comorbid substance abuse, and benzodiazepine discontinuation: implications for treatment. Treatment of Drug‐Dependent Individuals with Comorbid Mental Disorders, L S Onken, J D Blaine, S Genser, A M Horton. NIDA Research Monograph, U.S. Department of Health and Human Services, Rockville, MD 1997; Vol. 172: 33–51
   Google Scholar
• McGrath P J, Nunes E V, Stewart I W, Goldman D, Agosti V, Ocepek‐Welikson K, Quitkin F M. Imipramine treatment of alcoholics with primary depression. Arch Gen Psychiatry 1996; 53: 232–240, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar